OnKure Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:OKUR

Comments

OnKure Therapeutics Inc Earnings Estimates

OKURNASDAQ

Trade with Public

$2.88

0.051.77%

Last update: Mar 2, 4:03 PM

Overview NewsEarningsAnalyst Ratings Insider Trades Short Interest Stock Report

OnKure Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:OKUR

OnKure Therapeutics (OKUR) is scheduled to report Q4 earnings on March 17, 2026. Analysts estimate EPS of $-1.15 and quarterly revenue of N/A.

In the most recent quarter (Q3), OnKure Therapeutics reported EPS of $-1.09, beating estimates of $-1.20 by 0.09%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

OnKure Therapeutics has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, OnKure Therapeutics has averaged an EPS surprise of 0.29% and a revenue surprise of 0.00%.

Earnings Date

Mar 17

EPS Estimate

$-1.150

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

–

OnKure Therapeutics Earnings History

Analyze the earnings history of OnKure Therapeutics using advanced sorting and filters.

OnKure Therapeutics (OKUR) Earnings Per Share

The chart below shows OnKure Therapeutics's reported EPS compared to analyst estimates over recent quarters.

OnKure Therapeutics (OKUR) Revenue

The chart below shows OnKure Therapeutics's reported revenue compared to analyst estimates over recent quarters.

FAQ

When is OnKure Therapeutics (NASDAQ:OKUR) reporting earnings?

OnKure Therapeutics (OKUR) is scheduled to report earnings on May 5, 2026. The last reported earnings were for reported on November 6, 2025 for Q3.

What were the latest earnings per share (EPS) for OnKure Therapeutics (NASDAQ:OKUR)?

The Actual EPS was $-1.09, which beat the estimate of $-1.20.

What were OnKure Therapeutics’s (NASDAQ:OKUR) revenues?

The Actual Revenue was $0.00, which hit the estimate of $0.00.

People Also Watch

Estrella Immunopharma Inc

NASDAQ:ESLA

$1.18

3.51%

Aligos Therapeutics Inc

NASDAQ:ALGS

$7.03

0.93%

Atossa Therapeutics Inc

NASDAQ:ATOS

$4.50

Palatin Technologies Inc

AMEX:PTN

$21.00

-6.46%

Sensei Biotherapeutics Inc

NASDAQ:SNSE

$30.01

0.67%

Lisata Therapeutics Inc

XOMAO

OnKure Therapeutics Earnings Estimates, EPS & Revenue | NASDAQ:OKUR

OnKure Therapeutics (OKUR) is scheduled to report Q4 earnings on March 17, 2026. Analysts estimate EPS of $-1.15 and quarterly revenue of N/A.

In the most recent quarter (Q3), OnKure Therapeutics reported EPS of $-1.09, beating estimates of $-1.20 by 0.09%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.

OnKure Therapeutics has beaten EPS estimates in 3 consecutive quarters.

Over the last 4 quarters, OnKure Therapeutics has averaged an EPS surprise of 0.29% and a revenue surprise of 0.00%.

Earnings Date

Mar 17

EPS Estimate

$-1.150

Quarterly Revenue Estimate

–

Annual Revenue
(as of Sep 30)

–